GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNKF) » Definitions » Debt-to-EBITDA
中文

Bavarian Nordic A/S (Bavarian Nordic A/S) Debt-to-EBITDA

: 0.04 (As of Dec. 2023)
View and export this data going back to . Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

Bavarian Nordic A/S's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $7 Mil. Bavarian Nordic A/S's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $14 Mil. Bavarian Nordic A/S's annualized EBITDA for the quarter that ended in Dec. 2023 was $582 Mil. Bavarian Nordic A/S's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.04.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Bavarian Nordic A/S's Debt-to-EBITDA or its related term are showing as below:

BVNKF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -6.81   Med: 0.33   Max: 13.18
Current: 0.06

During the past 13 years, the highest Debt-to-EBITDA Ratio of Bavarian Nordic A/S was 13.18. The lowest was -6.81. And the median was 0.33.

BVNKF's Debt-to-EBITDA is ranked better than
89.89% of 277 companies
in the Biotechnology industry
Industry Median: 1.39 vs BVNKF: 0.06

Bavarian Nordic A/S Debt-to-EBITDA Historical Data

The historical data trend for Bavarian Nordic A/S's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.81 0.57 13.18 9.39 0.07

Bavarian Nordic A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 0.35 0.33 0.07 0.04

Competitive Comparison

For the Biotechnology subindustry, Bavarian Nordic A/S's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic A/S Debt-to-EBITDA Distribution

For the Biotechnology industry and Healthcare sector, Bavarian Nordic A/S's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic A/S's Debt-to-EBITDA falls into.



Bavarian Nordic A/S Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Bavarian Nordic A/S's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(6.81 + 14.449) / 313.438
=0.07

Bavarian Nordic A/S's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(6.81 + 14.449) / 582.18
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Bavarian Nordic A/S  (OTCPK:BVNKF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Bavarian Nordic A/S Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (Bavarian Nordic A/S) Headlines

From GuruFocus

Q1 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2023 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2020 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2020 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Bavarian Nordic A/S Conference Call Transcript

By GuruFocus Research 02-13-2024